| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-09-11 20:43:42 UTC |
|---|
| Update Date | 2021-09-14 15:43:40 UTC |
|---|
| HMDB ID | HMDB0061345 |
|---|
| Secondary Accession Numbers | - HMDB0061166
- HMDB61166
- HMDB61345
|
|---|
| Metabolite Identification |
|---|
| Common Name | N,N,O-Tridesmethylvenlafaxine |
|---|
| Description | N,N,O-Tridesmethylvenlafaxine is a metabolite of venlafaxine (brand name: Effexor or Efexor). Venlafaxine is a bicyclic antidepressant and is usually categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI), but it has been referred to as a serotonin-norepinephrine-dopamine reuptake inhibitor. It works by blocking the transporter reuptake proteins for key neurotransmitters affecting mood, thereby leaving more active neurotransmitters in the synapse. |
|---|
| Structure | NCC(C1=CC=C(O)C=C1)C1(O)CCCCC1 InChI=1S/C14H21NO2/c15-10-13(11-4-6-12(16)7-5-11)14(17)8-2-1-3-9-14/h4-7,13,16-17H,1-3,8-10,15H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-[2-Amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol | HMDB | | 4-[2-Amino-1-(1-hydroxycyclohexyl)ethyl]phenol | HMDB | | O-Desmethyl-N,N-didesmethylvenlafaxine | HMDB | | Tridesmethylvenlafaxine | HMDB |
|
|---|
| Chemical Formula | C14H21NO2 |
|---|
| Average Molecular Weight | 235.322 |
|---|
| Monoisotopic Molecular Weight | 235.157228921 |
|---|
| IUPAC Name | 4-[2-amino-1-(1-hydroxycyclohexyl)ethyl]phenol |
|---|
| Traditional Name | 4-[2-amino-1-(1-hydroxycyclohexyl)ethyl]phenol |
|---|
| CAS Registry Number | 149289-29-2 |
|---|
| SMILES | NCC(C1=CC=C(O)C=C1)C1(O)CCCCC1 |
|---|
| InChI Identifier | InChI=1S/C14H21NO2/c15-10-13(11-4-6-12(16)7-5-11)14(17)8-2-1-3-9-14/h4-7,13,16-17H,1-3,8-10,15H2 |
|---|
| InChI Key | BHCUWXACHAFFSK-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cyclohexanols. Cyclohexanols are compounds containing an alcohol group attached to a cyclohexane ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Alcohols and polyols |
|---|
| Direct Parent | Cyclohexanols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cyclohexanol
- Phenol
- Aralkylamine
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- Monocyclic benzene moiety
- Tertiary alcohol
- 1,3-aminoalcohol
- Cyclic alcohol
- Primary amine
- Amine
- Organonitrogen compound
- Primary aliphatic amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm √ó 2.1 mm; 1.7 Œºmparticle diameter). Predicted by Afia on May 17, 2022. | 2.7 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.7291 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.1 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1004.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 201.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 135.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 135.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 347.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 324.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 687.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 738.9 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 266.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 815.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 207.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.3 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 604.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 366.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 258.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N,N,O-Tridesmethylvenlafaxine,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C(CN)C2(O)CCCCC2)C=C1 | 2241.0 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,1TMS,isomer #2 | C[Si](C)(C)OC1(C(CN)C2=CC=C(O)C=C2)CCCCC1 | 2259.6 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,1TMS,isomer #3 | C[Si](C)(C)NCC(C1=CC=C(O)C=C1)C1(O)CCCCC1 | 2360.5 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C(CN)C2(O[Si](C)(C)C)CCCCC2)C=C1 | 2183.3 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TMS,isomer #2 | C[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C)C=C1)C1(O)CCCCC1 | 2277.4 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TMS,isomer #3 | C[Si](C)(C)NCC(C1=CC=C(O)C=C1)C1(O[Si](C)(C)C)CCCCC1 | 2322.0 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TMS,isomer #4 | C[Si](C)(C)N(CC(C1=CC=C(O)C=C1)C1(O)CCCCC1)[Si](C)(C)C | 2520.4 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #1 | C[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C)C=C1)C1(O[Si](C)(C)C)CCCCC1 | 2267.7 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #1 | C[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C)C=C1)C1(O[Si](C)(C)C)CCCCC1 | 2299.0 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #1 | C[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C)C=C1)C1(O[Si](C)(C)C)CCCCC1 | 2522.4 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C)[Si](C)(C)C)C2(O)CCCCC2)C=C1 | 2474.3 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C)[Si](C)(C)C)C2(O)CCCCC2)C=C1 | 2397.2 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C)[Si](C)(C)C)C2(O)CCCCC2)C=C1 | 2666.9 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #3 | C[Si](C)(C)OC1(C(CN([Si](C)(C)C)[Si](C)(C)C)C2=CC=C(O)C=C2)CCCCC1 | 2511.9 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #3 | C[Si](C)(C)OC1(C(CN([Si](C)(C)C)[Si](C)(C)C)C2=CC=C(O)C=C2)CCCCC1 | 2501.9 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TMS,isomer #3 | C[Si](C)(C)OC1(C(CN([Si](C)(C)C)[Si](C)(C)C)C2=CC=C(O)C=C2)CCCCC1 | 2652.3 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,4TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C)[Si](C)(C)C)C2(O[Si](C)(C)C)CCCCC2)C=C1 | 2493.7 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,4TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C)[Si](C)(C)C)C2(O[Si](C)(C)C)CCCCC2)C=C1 | 2431.8 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,4TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C)[Si](C)(C)C)C2(O[Si](C)(C)C)CCCCC2)C=C1 | 2447.5 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN)C2(O)CCCCC2)C=C1 | 2504.4 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1(C(CN)C2=CC=C(O)C=C2)CCCCC1 | 2514.1 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NCC(C1=CC=C(O)C=C1)C1(O)CCCCC1 | 2610.8 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN)C2(O[Si](C)(C)C(C)(C)C)CCCCC2)C=C1 | 2704.1 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1(O)CCCCC1 | 2783.9 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NCC(C1=CC=C(O)C=C1)C1(O[Si](C)(C)C(C)(C)C)CCCCC1 | 2834.7 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(CC(C1=CC=C(O)C=C1)C1(O)CCCCC1)[Si](C)(C)C(C)(C)C | 2953.3 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1(O[Si](C)(C)C(C)(C)C)CCCCC1 | 2989.2 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1(O[Si](C)(C)C(C)(C)C)CCCCC1 | 2897.7 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCC(C1=CC=C(O[Si](C)(C)C(C)(C)C)C=C1)C1(O[Si](C)(C)C(C)(C)C)CCCCC1 | 2801.2 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2(O)CCCCC2)C=C1 | 3174.8 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2(O)CCCCC2)C=C1 | 2964.1 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2(O)CCCCC2)C=C1 | 2900.2 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=CC=C(O)C=C2)CCCCC1 | 3192.1 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=CC=C(O)C=C2)CCCCC1 | 3053.7 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2=CC=C(O)C=C2)CCCCC1 | 2860.7 | Standard polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2(O[Si](C)(C)C(C)(C)C)CCCCC2)C=C1 | 3417.7 | Semi standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2(O[Si](C)(C)C(C)(C)C)CCCCC2)C=C1 | 3130.0 | Standard non polar | 33892256 | | N,N,O-Tridesmethylvenlafaxine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(C(CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C2(O[Si](C)(C)C(C)(C)C)CCCCC2)C=C1 | 2788.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - N,N,O-Tridesmethylvenlafaxine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9410000000-2a946521b39fd2a93a3a | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N,N,O-Tridesmethylvenlafaxine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N,N,O-Tridesmethylvenlafaxine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 10V, Positive-QTOF | splash10-014r-0090000000-a0bc5a6c99ec3135d880 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 20V, Positive-QTOF | splash10-0gb9-2190000000-8b1f9d70e7c8a356da89 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 40V, Positive-QTOF | splash10-1003-9210000000-5e3f08548da33fbadfed | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 10V, Negative-QTOF | splash10-001i-0090000000-da85f4b511ecb3f4b2d6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 20V, Negative-QTOF | splash10-0540-0590000000-f0d2e698e63813c65658 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 40V, Negative-QTOF | splash10-05n4-6910000000-b1db238b53f83db3c8d1 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 10V, Positive-QTOF | splash10-000i-0090000000-5281081ef386ecfc0d00 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 20V, Positive-QTOF | splash10-0udi-0490000000-ce3c55f2ff61365600df | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 40V, Positive-QTOF | splash10-0a4r-1910000000-b809532fd3d00ecd52fb | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 10V, Negative-QTOF | splash10-001i-0090000000-b855c6c1ebb7f3b3b541 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 20V, Negative-QTOF | splash10-0kai-1490000000-d133fac3a2db63708c7a | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N,N,O-Tridesmethylvenlafaxine 40V, Negative-QTOF | splash10-00l5-6940000000-4c882e5c165a4504ab0f | 2021-09-23 | Wishart Lab | View Spectrum |
|
|---|